Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome
BACKGROUND: Nitric oxide (NO) is predominantly a locally acting mediator, affecting several functions in the human female reproductive tract. In vivo, it is quickly metabolized to its stable end product nitrate, which is cleared by the kidney. METHODS AND RESULTS: The aim of the present study was to...
Gespeichert in:
Veröffentlicht in: | Human reproduction (Oxford) 2001-07, Vol.16 (7), p.1334-1339 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1339 |
---|---|
container_issue | 7 |
container_start_page | 1334 |
container_title | Human reproduction (Oxford) |
container_volume | 16 |
creator | Ekerhovd, E. Enskog, A. Caidahl, K. Klintland, N. Nilsson, L. Brännström, M. Norström, A. |
description | BACKGROUND: Nitric oxide (NO) is predominantly a locally acting mediator, affecting several functions in the human female reproductive tract. In vivo, it is quickly metabolized to its stable end product nitrate, which is cleared by the kidney. METHODS AND RESULTS: The aim of the present study was to evaluate possible fluctuations of plasma nitrate concentrations during the menstrual cycle, ovarian stimulation as well as ovarian hyperstimulation syndrome (OHSS). During the menstrual cycle (n = 19 women) the mean nitrate concentrations were between 26.7 and 29.5 μmol/l at all stages except for the day of ovulation, when the concentrations were significantly (P < 0.001) increased (mean 37.2 μmol/l ± 2.0). Significantly lower concentrations of plasma nitrate (P < 0.01) were measured at the end of gonadotrophin-releasing hormone (GnRH) down-regulation (24.6 μmol/l ± 1.4) compared with the concentrations found at day 8 of follicle-stimulating hormone (FSH) stimulation (34.9 μmol/l ± 2.6) and at the day of human chorionic gonadotrophin (HCG) (35.6 μmol/l ± 3.3). The concentrations of nitrate (33.4 μmol/l ± 3.4) in women with OHSS (n = 13) were similar to those seen 5 days after embryo transfer (33.2 μmol/l ± 2.3). CONCLUSIONS: The results indicate that NO synthesis is increased at the time of spontaneous ovulation. GnRH treatment inhibits NO synthesis, while NO production is not increased in women with OHSS. |
doi_str_mv | 10.1093/humrep/16.7.1334 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70966308</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/humrep/16.7.1334</oup_id><sourcerecordid>70966308</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-a9ac40f42c797cf0bbeba237383715a1f4afcde5cd5936c9c4c857d6df1739943</originalsourceid><addsrcrecordid>eNqNkEtP3DAUha2qVZnS7ruqvKjYlAx27NjxEhBTKiG1iyIhNtYdx-4YEjvYCWL-fTPNCFh2dV_fOVc6CH2mZEmJYiebsUu2P6FiKZeUMf4GLSgXpChZRd6iBSlFXVAq6AH6kPMdIVNbi_fogFJeVjVRC_T4q4XcATYxGBuGBIOPIePocPC7yeJmTD78wcPG4s6GPKQRWmy2prXHOD5C8hBwHnw3tv-0GELzvN9se5teH_M2NCl29iN656DN9tO-HqLr1cXv88vi6uf3H-enV4XhnAwFKDCcOF4aqaRxZL22ayiZZDWTtALqODjT2Mo0lWLCKMNNXclGNI5KphRnh-ho9u1TfBhtHnTns7FtC8HGMWtJlBCM1BNIZtCkmHOyTvfJd5C2mhK9y1rPWWsqtNS7rCfJl733uO5s8yLYhzsBX_cAZAOtSxCMz6-MOROETti3GYtj_z9fi5n2ebBPzzykey0kk5W-vLnVpBbidqVW-oz9BY6bqYc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70966308</pqid></control><display><type>article</type><title>Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome</title><source>Electronic Journals Library</source><source>MEDLINE</source><source>Oxford Journals Online</source><creator>Ekerhovd, E. ; Enskog, A. ; Caidahl, K. ; Klintland, N. ; Nilsson, L. ; Brännström, M. ; Norström, A.</creator><creatorcontrib>Ekerhovd, E. ; Enskog, A. ; Caidahl, K. ; Klintland, N. ; Nilsson, L. ; Brännström, M. ; Norström, A.</creatorcontrib><description>BACKGROUND: Nitric oxide (NO) is predominantly a locally acting mediator, affecting several functions in the human female reproductive tract. In vivo, it is quickly metabolized to its stable end product nitrate, which is cleared by the kidney. METHODS AND RESULTS: The aim of the present study was to evaluate possible fluctuations of plasma nitrate concentrations during the menstrual cycle, ovarian stimulation as well as ovarian hyperstimulation syndrome (OHSS). During the menstrual cycle (n = 19 women) the mean nitrate concentrations were between 26.7 and 29.5 μmol/l at all stages except for the day of ovulation, when the concentrations were significantly (P < 0.001) increased (mean 37.2 μmol/l ± 2.0). Significantly lower concentrations of plasma nitrate (P < 0.01) were measured at the end of gonadotrophin-releasing hormone (GnRH) down-regulation (24.6 μmol/l ± 1.4) compared with the concentrations found at day 8 of follicle-stimulating hormone (FSH) stimulation (34.9 μmol/l ± 2.6) and at the day of human chorionic gonadotrophin (HCG) (35.6 μmol/l ± 3.3). The concentrations of nitrate (33.4 μmol/l ± 3.4) in women with OHSS (n = 13) were similar to those seen 5 days after embryo transfer (33.2 μmol/l ± 2.3). CONCLUSIONS: The results indicate that NO synthesis is increased at the time of spontaneous ovulation. GnRH treatment inhibits NO synthesis, while NO production is not increased in women with OHSS.</description><identifier>ISSN: 0268-1161</identifier><identifier>ISSN: 1460-2350</identifier><identifier>EISSN: 1460-2350</identifier><identifier>DOI: 10.1093/humrep/16.7.1334</identifier><identifier>PMID: 11425809</identifier><identifier>CODEN: HUREEE</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Biological and medical sciences ; Chorionic Gonadotropin - administration & dosage ; Embryo Transfer ; Female ; Follicle Stimulating Hormone - administration & dosage ; Fundamental and applied biological sciences. Psychology ; Gonadotropin-Releasing Hormone - administration & dosage ; Humans ; in-vitro fertilization ; Kinetics ; Luteinizing Hormone - metabolism ; Mammalian female genital system ; Menstrual Cycle ; Morphology. Physiology ; nitrate ; Nitrates - blood ; nitric oxide ; ovarian hyperstimulation syndrome ; Ovarian Hyperstimulation Syndrome - blood ; Ovulation ; Ovulation Induction ; Recombinant Proteins - administration & dosage ; Reference Values ; Vertebrates: reproduction</subject><ispartof>Human reproduction (Oxford), 2001-07, Vol.16 (7), p.1334-1339</ispartof><rights>European Society of Human Reproduction and Embryology 2001</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-a9ac40f42c797cf0bbeba237383715a1f4afcde5cd5936c9c4c857d6df1739943</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1043601$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11425809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ekerhovd, E.</creatorcontrib><creatorcontrib>Enskog, A.</creatorcontrib><creatorcontrib>Caidahl, K.</creatorcontrib><creatorcontrib>Klintland, N.</creatorcontrib><creatorcontrib>Nilsson, L.</creatorcontrib><creatorcontrib>Brännström, M.</creatorcontrib><creatorcontrib>Norström, A.</creatorcontrib><title>Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome</title><title>Human reproduction (Oxford)</title><addtitle>Hum. Reprod</addtitle><addtitle>Hum. Reprod</addtitle><description>BACKGROUND: Nitric oxide (NO) is predominantly a locally acting mediator, affecting several functions in the human female reproductive tract. In vivo, it is quickly metabolized to its stable end product nitrate, which is cleared by the kidney. METHODS AND RESULTS: The aim of the present study was to evaluate possible fluctuations of plasma nitrate concentrations during the menstrual cycle, ovarian stimulation as well as ovarian hyperstimulation syndrome (OHSS). During the menstrual cycle (n = 19 women) the mean nitrate concentrations were between 26.7 and 29.5 μmol/l at all stages except for the day of ovulation, when the concentrations were significantly (P < 0.001) increased (mean 37.2 μmol/l ± 2.0). Significantly lower concentrations of plasma nitrate (P < 0.01) were measured at the end of gonadotrophin-releasing hormone (GnRH) down-regulation (24.6 μmol/l ± 1.4) compared with the concentrations found at day 8 of follicle-stimulating hormone (FSH) stimulation (34.9 μmol/l ± 2.6) and at the day of human chorionic gonadotrophin (HCG) (35.6 μmol/l ± 3.3). The concentrations of nitrate (33.4 μmol/l ± 3.4) in women with OHSS (n = 13) were similar to those seen 5 days after embryo transfer (33.2 μmol/l ± 2.3). CONCLUSIONS: The results indicate that NO synthesis is increased at the time of spontaneous ovulation. GnRH treatment inhibits NO synthesis, while NO production is not increased in women with OHSS.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Chorionic Gonadotropin - administration & dosage</subject><subject>Embryo Transfer</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - administration & dosage</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gonadotropin-Releasing Hormone - administration & dosage</subject><subject>Humans</subject><subject>in-vitro fertilization</subject><subject>Kinetics</subject><subject>Luteinizing Hormone - metabolism</subject><subject>Mammalian female genital system</subject><subject>Menstrual Cycle</subject><subject>Morphology. Physiology</subject><subject>nitrate</subject><subject>Nitrates - blood</subject><subject>nitric oxide</subject><subject>ovarian hyperstimulation syndrome</subject><subject>Ovarian Hyperstimulation Syndrome - blood</subject><subject>Ovulation</subject><subject>Ovulation Induction</subject><subject>Recombinant Proteins - administration & dosage</subject><subject>Reference Values</subject><subject>Vertebrates: reproduction</subject><issn>0268-1161</issn><issn>1460-2350</issn><issn>1460-2350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtP3DAUha2qVZnS7ruqvKjYlAx27NjxEhBTKiG1iyIhNtYdx-4YEjvYCWL-fTPNCFh2dV_fOVc6CH2mZEmJYiebsUu2P6FiKZeUMf4GLSgXpChZRd6iBSlFXVAq6AH6kPMdIVNbi_fogFJeVjVRC_T4q4XcATYxGBuGBIOPIePocPC7yeJmTD78wcPG4s6GPKQRWmy2prXHOD5C8hBwHnw3tv-0GELzvN9se5teH_M2NCl29iN656DN9tO-HqLr1cXv88vi6uf3H-enV4XhnAwFKDCcOF4aqaRxZL22ayiZZDWTtALqODjT2Mo0lWLCKMNNXclGNI5KphRnh-ho9u1TfBhtHnTns7FtC8HGMWtJlBCM1BNIZtCkmHOyTvfJd5C2mhK9y1rPWWsqtNS7rCfJl733uO5s8yLYhzsBX_cAZAOtSxCMz6-MOROETti3GYtj_z9fi5n2ebBPzzykey0kk5W-vLnVpBbidqVW-oz9BY6bqYc</recordid><startdate>20010701</startdate><enddate>20010701</enddate><creator>Ekerhovd, E.</creator><creator>Enskog, A.</creator><creator>Caidahl, K.</creator><creator>Klintland, N.</creator><creator>Nilsson, L.</creator><creator>Brännström, M.</creator><creator>Norström, A.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010701</creationdate><title>Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome</title><author>Ekerhovd, E. ; Enskog, A. ; Caidahl, K. ; Klintland, N. ; Nilsson, L. ; Brännström, M. ; Norström, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-a9ac40f42c797cf0bbeba237383715a1f4afcde5cd5936c9c4c857d6df1739943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Chorionic Gonadotropin - administration & dosage</topic><topic>Embryo Transfer</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - administration & dosage</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gonadotropin-Releasing Hormone - administration & dosage</topic><topic>Humans</topic><topic>in-vitro fertilization</topic><topic>Kinetics</topic><topic>Luteinizing Hormone - metabolism</topic><topic>Mammalian female genital system</topic><topic>Menstrual Cycle</topic><topic>Morphology. Physiology</topic><topic>nitrate</topic><topic>Nitrates - blood</topic><topic>nitric oxide</topic><topic>ovarian hyperstimulation syndrome</topic><topic>Ovarian Hyperstimulation Syndrome - blood</topic><topic>Ovulation</topic><topic>Ovulation Induction</topic><topic>Recombinant Proteins - administration & dosage</topic><topic>Reference Values</topic><topic>Vertebrates: reproduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ekerhovd, E.</creatorcontrib><creatorcontrib>Enskog, A.</creatorcontrib><creatorcontrib>Caidahl, K.</creatorcontrib><creatorcontrib>Klintland, N.</creatorcontrib><creatorcontrib>Nilsson, L.</creatorcontrib><creatorcontrib>Brännström, M.</creatorcontrib><creatorcontrib>Norström, A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ekerhovd, E.</au><au>Enskog, A.</au><au>Caidahl, K.</au><au>Klintland, N.</au><au>Nilsson, L.</au><au>Brännström, M.</au><au>Norström, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome</atitle><jtitle>Human reproduction (Oxford)</jtitle><stitle>Hum. Reprod</stitle><addtitle>Hum. Reprod</addtitle><date>2001-07-01</date><risdate>2001</risdate><volume>16</volume><issue>7</issue><spage>1334</spage><epage>1339</epage><pages>1334-1339</pages><issn>0268-1161</issn><issn>1460-2350</issn><eissn>1460-2350</eissn><coden>HUREEE</coden><abstract>BACKGROUND: Nitric oxide (NO) is predominantly a locally acting mediator, affecting several functions in the human female reproductive tract. In vivo, it is quickly metabolized to its stable end product nitrate, which is cleared by the kidney. METHODS AND RESULTS: The aim of the present study was to evaluate possible fluctuations of plasma nitrate concentrations during the menstrual cycle, ovarian stimulation as well as ovarian hyperstimulation syndrome (OHSS). During the menstrual cycle (n = 19 women) the mean nitrate concentrations were between 26.7 and 29.5 μmol/l at all stages except for the day of ovulation, when the concentrations were significantly (P < 0.001) increased (mean 37.2 μmol/l ± 2.0). Significantly lower concentrations of plasma nitrate (P < 0.01) were measured at the end of gonadotrophin-releasing hormone (GnRH) down-regulation (24.6 μmol/l ± 1.4) compared with the concentrations found at day 8 of follicle-stimulating hormone (FSH) stimulation (34.9 μmol/l ± 2.6) and at the day of human chorionic gonadotrophin (HCG) (35.6 μmol/l ± 3.3). The concentrations of nitrate (33.4 μmol/l ± 3.4) in women with OHSS (n = 13) were similar to those seen 5 days after embryo transfer (33.2 μmol/l ± 2.3). CONCLUSIONS: The results indicate that NO synthesis is increased at the time of spontaneous ovulation. GnRH treatment inhibits NO synthesis, while NO production is not increased in women with OHSS.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>11425809</pmid><doi>10.1093/humrep/16.7.1334</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0268-1161 |
ispartof | Human reproduction (Oxford), 2001-07, Vol.16 (7), p.1334-1339 |
issn | 0268-1161 1460-2350 1460-2350 |
language | eng |
recordid | cdi_proquest_miscellaneous_70966308 |
source | Electronic Journals Library; MEDLINE; Oxford Journals Online |
subjects | Adult Biological and medical sciences Chorionic Gonadotropin - administration & dosage Embryo Transfer Female Follicle Stimulating Hormone - administration & dosage Fundamental and applied biological sciences. Psychology Gonadotropin-Releasing Hormone - administration & dosage Humans in-vitro fertilization Kinetics Luteinizing Hormone - metabolism Mammalian female genital system Menstrual Cycle Morphology. Physiology nitrate Nitrates - blood nitric oxide ovarian hyperstimulation syndrome Ovarian Hyperstimulation Syndrome - blood Ovulation Ovulation Induction Recombinant Proteins - administration & dosage Reference Values Vertebrates: reproduction |
title | Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A31%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20concentrations%20of%20nitrate%20during%20the%20menstrual%20cycle,%20ovarian%20stimulation%20and%20ovarian%20hyperstimulation%20syndrome&rft.jtitle=Human%20reproduction%20(Oxford)&rft.au=Ekerhovd,%20E.&rft.date=2001-07-01&rft.volume=16&rft.issue=7&rft.spage=1334&rft.epage=1339&rft.pages=1334-1339&rft.issn=0268-1161&rft.eissn=1460-2350&rft.coden=HUREEE&rft_id=info:doi/10.1093/humrep/16.7.1334&rft_dat=%3Cproquest_cross%3E70966308%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70966308&rft_id=info:pmid/11425809&rft_oup_id=10.1093/humrep/16.7.1334&rfr_iscdi=true |